ro, was speaking Saturday during a seminar at the ADB’s annual meeting in Yokohama, which wrapped up Sunday. He led the Manila-based development lender from 2005 until 2013.Kuroda reaffirmed the BOJ’s April forecast that inflation in Japan should reach the 2 percent target in around the fiscal year that starts in April 2018 and ends in March 2019. He added that the task is challenging.Asked which job was harder, the ADB or the BOJ, Kuroda joked: “;I can say it like this, the ADB presidency is certainly more exciting t
han governorship of Bank of Japan, but certainly central banking is sometimes more complicated and difficult.”The ADB gathering in Yokohama is the first time in a decade that the institution has had its annual meeting in Japan, its largest source of funding. It comes as a new China-backed development bank ramps up lending across the region.The ADBR17;s current president, Takehiko Nakao, said in an earlier interview that there has been more cooperation than competition with the Beijing-based Asian Infrastructure Investment Bank.Japan and the U.S. both
declined to join the AIIB, which now has 70 approved members, more than the 67 countries and territories that are part of the ADB.TwitterFacebookLinkedInGET THE BEST OF
THE JAPAN TIMESIN FIVE EASY PIECES WITH TAKE 5Mail the editorError ReportRepublishingCommenting PolicyJOIN THE CONVERSATIONLATEST BUSINESS STORIESWorkplace equality 'decades away' in Britain as men dominate top jobsEquality for women at work is decades away in Britain, according to a study released Monday that found just 6 percent of chief executives at leading companies are female, with representation in som...Tsai's election victory set to bolster Taiwan's buoyant marketsA winning run for Taiwan's financial markets is set to be reinforced by Saturday's landslide election victory for President Tsai Ing-wen.That's the view of market watchers and analysts, with th...Ex-drug company execs face reckoning in opioid bribery caseThe founder and former top employees of a pharmaceutical company are facing a reckoning for their role in a bribery scheme that prosecutors say boosted sales of a powerful, highly addictive painkil...